DescriptionSummary : Seattle Genetics is preparing to launch tucatinib, a highly selective tyrosine kinase inhibitor (TKI), for HER2+ metastatic breast cancer patients in Europe.
In this role, you will lead development of the Spanish Market Access strategy for the company’s oncology pipeline. Specifically, the Director, Value Access & Pricing, Spain will lead efforts in assessing and communicating to internal and external stakeholders the market access requirements of Spain for oncology, contributing to and shaping the overall value strategy for our brands throughout lifecycle.
The position will drive development of local market access strategy, delivery of HTA submissions, and lead P&R negotiations.
The position will report into the GM, Spain, and collaborate closely with the Head of VAP for Europe a dotted line manager for this role.
establish pricing position within EU Price Band;Collaborate closely with relevant internal stakeholders, including Marketing, Medical Affairs, Regulatory, etc.
Qualifications : Degree in Health Economics, Health Research, Pharmacy or a relevant related discipline8+ years of experience within the field of Market Access, Health Economics, Outcomes ResearchStrong network of relevant stakeholders in SpainStrong oncology market knowledge from a commercial and clinical studies perspectiveExcellent communication and negotiation skillsBusiness fluency in EnglishFluency in local language is a mustAs a leading employer in our industry, Seattle Genetics is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families.
To learn more about Seattle Genetics, please visit .Seattle Genetics is an equal opportunity employer. All qualified applications will receive consideration for employment.